Use of C-reactive protein in pediatric patients with renal diseases
Keywords:
C-REACTIVE PROTEIN, KIDNEY DISEASES, BLOOD SEDIMENTATIONAbstract
Background: the use of C-reactive protein as an inflammatory marker in various conditions is part of novel studies in the field of many specialties such as cardiology and immunology.
Objective: to assess the usefulness of C-reactive protein for the diagnosis of renal diseases in pediatric patients attended to at the Eduardo Agramonte Piña Pediatric Hospital in the municipality of Camagüey from April 2014 to January 2015.
Methods: a prospective, longitudinal and analytical study was carried out at the nephrology service of the aforementioned hospital and during the period already stated. The universe consisted of the patients who were admitted with the diagnosis of post-infectious glomerulonephritis, nephrotic syndrome and urinary tract infections of the 1 to 13 age group. The sample was made up of 60 patients with less than 48 hours after the onset of the signs and symptoms of the disease. The values of C-reactive protein and erythrocyte sedimentation rate were determined, and the specificity, sensitivity and predictive value for both laboratory tests were calculated.
Results: the diagnosis of urinary infection predominated in 29 (48,3 %) of the studied patients; 39 (65 %) had high levels of erythrocyte sedimentation and 48 (80 %) had high C-reactive protein levels. The sensitivity and the predictive value for the C-reactive protein were higher than the erythrocyte sedimentation.
Conclusions: the study supports the use of the C-reactive protein as an inflammatory marker in renal processes.
Downloads
References
Pérez-Oliva Díaz JF. Coordinador general. Programa enfermedad renal, diálisis y transplante [en línea] Sociedad Cubana de Nefrología. Instituto Nacional de Nefrologia “Dr. Abelardo Buch Lopez”; 2012 [citado 31 de marzo 2017]. Disponible en: http://files.sld.cu/nefrologia/files/2013/06/anuario-nefrologia-2012.pdf.
Vargas M F. Coordinador. Documento Marco sobre Enfermedad Renal Crónica (ERC) dentro de la Estrategia de Abordaje a la Cronicidad en el SNS. [en línea]. España; 2015 [citado 31 de marzo 2017]. Disponible en: http://www.msssi.gob.es/organizacion/sns/planCalidadSNS/pdf/Enfermedad_Renal_Cronica_2015.pdf.
MINSAP. Boletín fotográfico de la Biblioteca Médica Nacional. Fotográfico de salud [en línea]; 2016, febrero. Enfermedades renales. Estadísticas mundiales Vol.2 No.2 ANPS 2433 [citado 31 de marzo 2017]. Disponible en: http://www.sld.cu/anuncio/2016/02/16/factografico-de-salud-feb-2016-enfermedades-rena les-estadisticas-mundiales.
Moyses Neto M, Barros Silva GE, S. Costa R, A. Romão E, Vieira Neto OM, Dantas M. Glomerulopatía de lesões mínimas associada ao diabetes melito do tipo 1 e do tipo 2. Case report. Arq Bras Endocrinol Metab [revista en internet]. 2012 [citado 31 de marzo 2017]; 56(5). Disponible en: http://www.scielo.br/ pdf/abem/v56n5/a09v56n5.pdf.
Hitsumoto T. Clinical significance of the augmentation Index in patients with preserved kidney function. J Nippon Med Sch [revista en internet]. 2012 [citado 31 de marzo 2017]; 79(6): 422-9. Disponible en: https://www.jstage.jst.go.jp/article/jnms/79/6/79_422/_article/-char/ja/.
de Boer IH, Katz R, Chonchol MB, Fried LF, Ix JH, Kestenbaum B, et al. Insulin Resistance, Cystatin C, and Mortality among Older Adults. Diabetes Care [revista en internet]. 2012 [citado 31 de marzo 2017]; 35(6): 1355-60. Disponible en: http://care.diabetesjournals.org/content/35/6/1355.short.
Barcellos FC, Santos IS, Mielke GI, Del Vecchio FB and Hallal PC. Effects of exercise on kidney function among non-diabetic patients with hypertension and renal disease: randomized controlled trial. BMC Nephrol [revista en internet]. 2012, Agos [citado 31 de marzo 2017]; 13(1): 90. Disponible en: https://bmcnephrol.biomedcentral.com/articles/10.1186/1471-2369-13-90.
Bamonde L, Caamaño B, Alonso M. La procalcitonina como marcador de infección. Una revisión desde atención primaria. Revista pediátrica de atención primaria [revista en internet]. 2002 [citado 31 de marzo 2017]; 4(16): 617-630. Disponible en: http://www.pap.es/files/1116-261-pdf/268.pdf.
Rothenbacher D, Klenk J, Denkinger M, Karakas M, Nikolaus T, Peter R, et al. Prevalence and determinants of chronic kidney disease in community-dwelling elderly by various estimating equations. BMC Public Health [revista en internet]. 2012 [citado 31 de marzo 2017]; 12(1): 343. Disponible en: https://bmcpublic health.biomedcentral.com/articles/10.1186/1471-2458-12-343.
Pagels AA, Söderkvist BK, Medin C, Hylander B, Heiwe S. Health-related quality of life in different stages of chronic kidney disease and at initiation of dialysis treatment. Health Qual Life Outcomes [revista en internet]. 2012 [citado 31 de marzo 2017]; 10(1): 71. Disponible en: https://hqlo.biomedcentral.com/ articles/10.1186/1477-7525-10-71.
Ito C, Akimoto T, Nakazawa E, Komori S, Sugase T, Chinda J, et al. A case of cervical cancer-related membranous nephropathy treated with radiation therapy. Intern Med [revista en internet]. 2011 [citado 31 de marzo 2017]; 50(1): 47-51. Disponible en: https://www.jstage.jst.go.jp/article/internalmedicine/50/1/ 50_1_47/_article/-char/ja/.
Mori S, Matsushita Y, Arizono K. Minimal change nephrotic syndrome associated with Isoniazid in anti-tuberculosis chemoprophylaxis for a patient with rheumatoid arthritis. Intern Med [revista en internet]. 2011 [citado 31 de marzo 2017]; 50(3): 253-7. Disponible en: https://www.jstage.jst.go.jp/article/internal medicine/50/3/50_3_253/_article/-char/ja/.
Guyton AC, Hall JE. Textbook of Medical Physiology. 11th ed. Philadelphia: Elsevier Saunders; 2006.
14. Shih LY, Wu JJ, Yang DJ. Erythrocyte sedimentation rate and C-reactive protein values in patients with total hip arthroplasty. Clin Orthop Relat Res [revista en internet]. 1987 [citado 31 de marzo 2017]; (225): 238-46. Disponible en: http://journals.lww.com/corr/abstract/1987/12000/erythrocyte_sedimentation_rate_and _c_reactive.21.aspx.
Fincher RM, Page MI. Clinical significance of extreme elevation of the erythrocyte sedimentation rate. Arch Intern Med [revista en internet]. 1986 [citado 31 de marzo 2017]; 146(8): 1581-3. Disponible en: http://archinte.jamanetwork.com/article.aspx?articleid=607189.
Lluberas-Acosta G, Schumacher HR Jr. Markedly elevated erythrocyte sedimentation rates: consideration of clinical implications in a hospital population. Br J Clin Pract [revista en internet]. 1995 [citado 31 de marzo 2017]; 50(3): 138-42. Disponible en: http://europepmc.org/abstract/med/8733332.
Pritchard-Jones K, Kaatsch P, Steliarova-Foucher E, Stiller CA, Coebergh JWW. Cancer in children and adolescents in Europe: developments over 20 years and future challenges. Eur J Cancer [revista en internet]. 2006 [citado 31 de marzo 2017]; 42(13): 2183-2190. Disponible en: http://www.sciencedirect. com/science/article/pii/S0959804906004850.
Phillips RS, Wade R, Lehrnbecher T, Stewart LA, Sutton AJ. Systematic review and meta-analysis of the value of initial biomarkers in predicting adverse outcome in febrile neutropenic episodes in children and young people with cancer. BMC Med [revista en internet]. 2012 [citado 31 de marzo 2017]; 10(1): 6. Disponible en: https://bmcmedicine.biomedcentral.com/articles/10.1186/1741-7015-10-6.
Doval HC. En búsqueda del factor de riesgo perdido: la cuestión de la proteína C reactiva. Rev. argent. Cardiol [revista en internet]. 2006 [citado 31 de marzo 2017]; 74(6). Disponible en: http://www.scielo.org. ar/scielo.php?script=sci_arttext&pid=S1850-37482006000600016.
Brotman DJ, Walker E, Lauer MS, O'Brien RG. In search of fewer independent risk factors. Arch Intern Med [revista en internet]. 2005 [citado 31 de marzo 2017]; 165(2): 138-45. Disponible en: http://jamanetwork. com/journals/jamainternalmedicine/fullarticle/486377.
Greenland P, O'Malley PG. When is a new prediction marker useful? A consideration of lipoprotein-associated phospholipase A2 and C-reactive protein for stroke risk. Arch Intern Med [revista en internet]. 2005 [citado 31 de marzo 2017]; 165(21): 2454-6. Disponible en: http://jamanetwork.com/journals/jama internalmedicine/fullarticle/486799.
Lloyd-Jones DM, Liu K, Tian L, Greenland P. Narrative review: Assessment of C-reactive protein in risk prediction for cardiovascular disease. Ann Intern Med [revista en internet]. 2006 [citado 31 de marzo 2017]; 145(1): 35-42. Disponible en: http://annals.org/aim/article/725141/narrative-review-assessment-c-reactive-protein-risk-prediction-cardiovascular-disease.
Secmeer G, Devrim I, Kara A, Ceyhan M, Cengiz B, Kutluk T, et al. Role of procalcitonin and CRP in differentiating a stable from deteriorating clinical course in pediatric febrile neutropenia. J Pediatr Hematol Oncol [revista en internet]. 2007 [citado 31 de marzo 2017]; 29(2):107-111. Disponible en: http://journals.lww.com/jpho-online/Abstract/2007/02000/Role_of_Procalcitonin_and_CRP_in_Differentiating _a.6.aspx.
El-Maghraby SM, Moneer MM, Ismail MM, Shalaby LM, El-Mahallawy HA. The diagnostic value of C-reactive protein, interleukin-8, and monocyte chemotactic protein in risk stratification of febrile neutropenic children with hematologic malignancies. J Pediatr Hematol Oncol [revista en internet]. 2007 [citado 31 de marzo 2017]; 29(3): 131-136. Disponible en: http://journals.lww.com/jpho-online/Abstract/2007/03000/The _Diagnostic_Value_of_C_reactive_Protein,.1.aspx.
Mendoza Coussette U, Rodríguez González JA, Alonso Biosca ME. Marcadores de respuesta inflamatoria y riesgo coronario en pacientes con artritis reumatoide. Rev cubana Invest Bioméd [revista en internet]. 2013 [citado 31 de marzo 2017]; 32(3). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext& pid=S0864-03002013000300009.
Sánchez-Yepes M. Utilización de pro calcitonina y proteína C reactiva como marcadores de infección en la neutropenia febril de pacientes sometidos a trasplante de progenitores hematopoyéticos. Enfermedades Infecciosas y Microbiologia Clinica [revista en internet]. 2014 [citado 31 de marzo 2017]; 32(7): 418-423. Disponible en: http://www.sciencedirect.com/science/article/pii/S0213005X13002474.
López Cuenca Á, Manzano S. Interleucina 6 y proteína C reactiva ultrasensible para la predicción de la evolución clínica en síndromes coronarios agudos sin elevación del segmento ST. Revista Española de Cardiología [revista en internet]. 2013 [citado 31 de marzo 2017]; 66(3): 185-192. Disponible en: http://www.sciencedirect.com/science/article/pii/S0300893212005544.
Scholze A, Bladbjerg EM, Sidelmann JJ, CP Diederichsen A, Mickley H, Nybo M, et al. Plasma concentration of extracellular matrix protein fibulin 1 are related to cardiovascular risk markers in chronic kidney disease and diabetes. Cardiovasc Diabetol [revista en internet]. 2013 [citado 31 de marzo 2017]; 12(1): 6. Disponible en: https://cardiab.biomedcentral.com/articles/10.1186/1475-2840-12-6.
Downloads
Published
How to Cite
Issue
Section
License
This journal provides free and immediate access to its content under the principle that making research freely available to the public supports a greater exchange of global knowledge. This means that the authors transfer the copyright to the journal, so that copies and distribution of the contents can be made by any means, as long as the authors' acknowledgment is maintained. These terms are a reflection that the journal assumes copyright under Creative Commons licenses, specifically under a Creative Commons Attribution 4.0 International license.
Registration and submission of articles to the journal is free. The processing, including review, editing and publication, is completely free of charge.